Should I add lisinopril to the treatment regimen of a 71-year-old asymptomatic female patient with mildly elevated blood pressure on metoprolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypertension in a 71-Year-Old Female on Metoprolol

For a 71-year-old asymptomatic female with BP 136/76 on metoprolol, adding lisinopril is not recommended as the current blood pressure is adequately controlled and below target thresholds for her age group. 1

Blood Pressure Assessment and Targets

  • The patient's current BP of 136/76 mmHg is:

    • Below the target of <150/90 mmHg recommended for adults aged ≥60 years 1
    • Within acceptable range for older adults (target 130-140/70-79 mmHg for patients ≥65 years) 1
  • Blood pressure classification:

    • This BP reading falls within Stage 1 Hypertension range (130-139/80-89 mmHg) 1
    • However, for patients >70 years old, this is considered well-controlled

Treatment Decision Algorithm

  1. Current Status Assessment:

    • Patient is asymptomatic
    • BP is 136/76 mmHg on metoprolol
    • BP is below the recommended target of <150/90 mmHg for her age group
  2. Guideline-Based Decision:

    • For Stage 1 hypertension with BP goal <130/80 mmHg, initiation with a single antihypertensive drug is reasonable with sequential addition only if target is not achieved 2
    • The patient's current BP is already below the age-appropriate target of <150/90 mmHg
  3. Recommendation:

    • Continue current therapy with metoprolol
    • No need to add lisinopril at this time
    • Monitor BP regularly to ensure continued control

Rationale for Not Adding Lisinopril

  • The 2017 ACC/AHA guidelines recommend initiating treatment with 2 agents only for Stage 2 hypertension with BP >20/10 mmHg above target 2
  • This patient's BP is already controlled below the recommended target for her age group
  • Adding unnecessary medication increases risk of:
    • Adverse effects (cough, hyperkalemia with ACE inhibitors) 1
    • Drug interactions
    • Potential hypotension in older adults 2

Important Monitoring Considerations

  • Continue to monitor BP regularly, ideally with home BP monitoring 1
  • Measure BP in both arms at follow-up visits (difference >10 mmHg associated with increased cardiovascular risk) 1
  • Ensure proper positioning during BP measurement (back supported, legs uncrossed, arm at heart level) 1
  • If BP rises above target in future visits, consider adding a second agent at that time

Caveat

  • If the patient has compelling indications not mentioned (diabetes, chronic kidney disease, heart failure, or prior stroke), treatment targets may be lower and adding lisinopril might be considered despite current BP control 1
  • For patients with specific comorbidities requiring more aggressive BP targets (<140/90 mmHg), reassess the need for additional therapy 1

References

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.